drugset / Trial / NCT01871740
CSPPT- Chronic Kidney Diseases Study
Phase 4
Withdrawn
Shenzhen Ausa Pharmed Co.,Ltd
Nanfang Hospital, Southern Medical University · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this trial is to confirm that enalapril maleate and folic acid tablets is more effective in preventing renal function decline among the patients with primary hypertension when compared to enalapril maleate.
Timeline
- Start
- 2008-05
- Primary completion
- 2014-06
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | folic acid | Other / unclassified | 0.8 mg | Oral |
| Comparator | Enalapril | Other / unclassified | 10 mg | Oral |